Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus-version 4.0.

ESMO gastrointestinal oncology·2026

Same author

Early image acquisition <sup>68</sup>Ga-FAPI-46-PET/CT in prone position is promising in the workup of rectosigmoid and anal carcinoma.

European journal of nuclear medicine and molecular imaging·2025

Same author

Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK.

The Journal of hospital infection·2024

Same author

Detection of sub-nmol amounts of the antiviral drug favipiravir in <sup>19</sup>F MRI using photo-chemically induced dynamic nuclear polarization.

Scientific reports·2024

Same author

Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

TEsoNet: knowledge transfer in surgical phase recognition from laparoscopic sleeve gastrectomy to the laparoscopic part of Ivor-Lewis esophagectomy.

Surgical endoscopy·2023

Same journal

[S3 Guideline "Adult soft tissue sarcomas"].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022

Same journal

[Synopsis-S3 guidelines pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022

Same journal

[Laparoscopic sentinel node navigation surgery in gastric cancer to reduce surgical radicality].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022

Same journal

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022

Same journal

[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022

Same journal

[Surgical treatment of pancreatic cancer-What is new?]

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022

See all related articles

Search research articles

Related Experiment Video

Updated: May 9, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8⁺ T Cells in Mice

Published on: June 12, 2021

[Tumor and transplantation].

M Guba¹, J Andrassy, M Angele

¹Klinik für Allgemeine-, Viszeral-, Transplantations-, Gefäß- und Thoraxchirurgie, Klinikum der Universität München, Campus Grosshadern, Marchioninistr. 15, 81377, München, Deutschland. Markus.Guba@med.uni-muenchen.de

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen

|July 9, 2013

Summary

This summary is machine-generated.

Organ transplantation can be an effective cancer treatment, but immunosuppression may increase tumor risk. mTOR inhibitors show anti-tumor effects, making them ideal for transplant patients with high cancer risk.

More Related Videos

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

Published on: February 11, 2014

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Related Experiment Videos

Last Updated: May 9, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8⁺ T Cells in Mice

Published on: June 12, 2021

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

Published on: February 11, 2014

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Area of Science:

Oncology and Transplant Surgery
Immunology and Pharmacology

Context:

Transplantation is a vital treatment for early-stage primary tumors.
Mandatory immunosuppression post-transplantation can paradoxically promote tumor recurrence and de novo malignancies.
Immunosuppression significantly elevates cancer rates in organ transplant recipients.

Purpose:

To elucidate the complex relationship between cancer treatment via transplantation and the necessity of immunosuppression.
To review the scientific basis of tumor development and recurrence in transplant patients.
To highlight the differential impact of immunosuppressants on tumor growth.

Summary:

While transplantation offers a treatment for certain primary tumors, the required immunosuppression poses a risk for tumor recurrence and new cancers.
Not all immunosuppressive agents affect tumors equally.
Mechanistic Target of Rapamycin (mTOR) inhibitors demonstrate significant anti-tumoral properties.
mTOR inhibitors are recommended for immunosuppression in transplant candidates with elevated cancer risk.

Impact:

Provides critical insights for optimizing immunosuppressive strategies in transplant oncology.
Informs clinical decision-making for managing cancer risk in organ recipients.
Supports the use of targeted immunosuppression to balance transplant success and cancer prevention.